How do I find out if I qualify for a recurrent diffuse large b-cell lymphoma study in Oregon?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Oregon to take part?

Not necessarily. These studies have a site in Oregon, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a recurrent diffuse large b-cell lymphoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Oregon

Recurrent Diffuse Large B-Cell Lymphoma clinical trials in Oregon

We’re tracking 4 recruiting recurrent diffuse large b-cell lymphoma studies with a site in Oregon — including Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Oregon

NCT06649812RecruitingPhase 2
Testing a combination targeted therapy (ViPOR) for aggressive B-cell lymphoma
This trial tests a new combination of targeted drugs called ViPOR for people with aggressive B-cell lymphoma that has come back or not responded to previous treatment. The goal is to see if this treatment can help when standard therapies haven't worked.
Newberg, OregonAges 18 years+
NCT04792489RecruitingPhase 2
CAR-T cell therapy for aggressive B-cell lymphomas
This trial tests a new CAR-T cell treatment (MB-CART2019.1) for people with certain types of aggressive B-cell non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL) that has come back or not responded to prior treatments. It aims to see if this therapy can help when other options have failed.
Portland, OregonAges 18 years+
NCT05633615RecruitingPhase 2
Testing new drug options after CAR T for aggressive lymphoma
This Phase 2 study tests whether adding or switching drug treatments after CAR T-cell therapy can improve outcomes for people with certain aggressive lymphomas that have come back or did not respond. It mainly looks at who remains disease-stable/partly improved after CAR T and what treatment approach works best next.
Portland, OregonAges 18 years+
NCT05890352RecruitingPhase 2
Add new medicines to standard treatment for returning lymphoma
This Phase 2 study tests whether adding tafasitamab, lenalidomide, tazemetostat, and zanubrutinib (along with standard lymphoma treatment) can improve outcomes in people whose large B-cell lymphoma has returned or not responded. It may help control disease more effectively and improve response duration for eligible patients.
Portland, OregonAges 18 years+

Recurrent Diffuse Large B-Cell Lymphoma trials by city in Oregon

Portland

Where these studies are running in Oregon

Institutions with a site for the recruiting recurrent diffuse large b-cell lymphoma studies listed above.

Providence Newberg Medical Center · 3 studies
Providence Portland Medical Center · 3 studies
Providence Saint Vincent Medical Center · 3 studies
Providence Willamette Falls Medical Center · 3 studies
Oregon Health & Science University (OHSU) - Knight Cancer Institute
Oregon Health and Science University

What taking part in a recurrent diffuse large b-cell lymphoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Recurrent Diffuse Large B-Cell Lymphoma trials in other states

Common questions

Are there recurrent diffuse large b-cell lymphoma clinical trials in Oregon?: Yes. We're currently tracking 4 recruiting recurrent diffuse large b-cell lymphoma studies with a site in Oregon, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a recurrent diffuse large b-cell lymphoma study in Oregon?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Oregon to take part?: Not necessarily. These studies have a site in Oregon, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a recurrent diffuse large b-cell lymphoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New recurrent diffuse large b-cell lymphoma studies open in Oregon regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.